Signaling pathways
-
BA5346 PF-5190457Summary: PF-5190457 (PF-05190457) is a potent, selective growth hormone-releasing peptide receptor inverse agonist. - BA5347 TM-N1324Summary: TM-N1324 is an agonist of G protein-coupled receptor 39.
- BA5348 AZP-531Summary: A nonglycated growth hormone-releasing peptide analog for improving glycemic control and reducing body weight.
- BA5349 L-692429Summary: L-692429 (MK-0751) is a benzolactam derivative and a nonpeptidyl growth hormone agonist.
- BA5350 PF-04628935Summary: PF-04628935 is a potent receptor inverse agonist.
- BA5351 AZ-GHS-22Summary: A potent non-CNS-permeable inverse agonist (=0.77 nM).
- BA5352 SurvodutideSummary: Survodutide (BI456906) is a potent and selective dual glucagon receptor/GLP-1 receptor agonist with values of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively.
- BA5353 MazdutideSummary: Mazdutide (IBI-362; LY-3305677) is a long-acting synthetic gastrin regulator analog.
- BA5354 ApraglutideSummary: Apraglutide (FE203799) is a synthetic 33-amino acid peptide and long-acting GLP-2 analog.
- BA5355 V-0219Summary: V-0219 is an orally active glucagon-like peptide-1 receptor positive allosteric modulator (PAM).